openPR Logo
Press release

Respiratory Disease Testing Market to Sour at a CAGR of 5.14% by 2030, Evaluates DelveInsight | Koninklijke Philips N.V., Niterra Co., Ltd., Thermo Fisher Scientific Inc., QIAGEN, Abbott, Danaher Corporation, Siemens Healthineers

08-20-2024 05:44 AM CET | Health & Medicine

Press release from: DelveInsight Business Research

Respiratory Disease Testing Market

Respiratory Disease Testing Market

As per DelveInsight's assessment, the Respiratory Disease Testing Market is expected to grow at an immense pace in the coming years owing to the The increasing prevalence of pandemic such as COVID-19, Pre- and post-operation and some few of the other applications where Respiratory Disease Testing have been used, which is expected to drive the demand for Respiratory Disease Testing in the upcoming years.

DelveInsight's "Respiratory Disease Testing Market Insights, Competitive Landscape, and Market Forecast - 2030" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Respiratory Disease Testing companies actively working in the market.

Interested in knowing how the Respiratory Disease Testing market will grow by 2030? Click to get a snapshot of the Respiratory Disease Testing Market Analysis
https://www.delveinsight.com/sample-request/respiratory-disease-testing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Respiratory Disease Testing Overview
Respiratory Disease Testing are specialized medical devices used in various interventional procedures to navigate the body's complex vascular system. These catheters are designed with flexible, steerable tips that can be precisely controlled by the operator. This flexibility allows the catheters to reach difficult-to-access areas within the body, making them essential tools in procedures such as cardiac electrophysiology, ablation therapies, and vascular interventions.

DelveInsight Analysis: The global respiratory disease testing market size reached a valuation of USD 6.40 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 4.29% from 2024 to 2030, aiming to achieve USD 8.55 billion by 2030.

Respiratory Disease Testing Market Insights
Geographically, North America is projected to dominate the Respiratory Disease Testing market among all regions. This dominance is attributed to the significant number of patients with cardiovascular conditions like heart attacks and coronary artery diseases (CAD), as well as respiratory issues such as COPD, particularly in the US. Additionally, the adoption of advanced medical equipment, supported by strong regulatory frameworks in the region, is anticipated to propel the market for Respiratory Disease Testing in North America throughout the forecast period.

To know more about why North America is leading the market growth in the Respiratory Disease Testing market, get a snapshot of the report Respiratory Disease Testing Market Trends
https://www.delveinsight.com/report-store/respiratory-disease-testing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Recent Developments in the Respiratory Disease Testing Market Report
• In March 2021, Abbott obtained FDA Emergency Use Authorization (EUA) for its Alinity™ m Resp-4-Plex molecular assay, allowing for the simultaneous identification and differentiation of SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV) with a single test.
• In July 2023, United Imaging, a leading global producer of advanced medical imaging and radiotherapy devices, introduced its newest generation of PET/CT Systems and Integrated Molecular Technology at the SNMMI conference.
• Thus, owing to such developments in the market, rapid growth will be observed in the Respiratory Disease Testing market during the forecast period

To read more about the latest highlights related to Respiratory Disease Testing, get a snapshot of the key highlights entailed in the Respiratory Disease Testing
https://www.delveinsight.com/sample-request/respiratory-disease-testing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Key Players in the Respiratory Disease Testing Market
Some of the key market players operating in the Respiratory Disease Testing market include- Koninklijke Philips N.V., Niterra Co., Ltd., Thermo Fisher Scientific Inc., QIAGEN, Abbott, Danaher Corporation, Siemens Healthineers, Diasorin S.p.A, BD, GE Healthcare, QuantuMDx Group Ltd., BIOMÉRIEUX, SDI Diagnostics, COSMED srl, Seegene Inc., CAREstream Medical Ltd., Bird Healthcare, visby medical, Vitalograph, Bio-Rad Laboratories, Inc., and others.

COVID-19 Impact Analysis on the Respiratory Disease Testing Market
Challenges such as the expensive nature of respiratory diagnostic equipment and rigorous regulatory clearance procedures for these devices could potentially hinder the growth trajectory of the respiratory disease testing market.

Additionally, The increasing incidence of respiratory disorders worldwide is a major driver for the growing demand in respiratory disease testing. Moreover, elevated risks linked to respiratory ailments and ongoing advancements in product development and regulatory approvals are pivotal factors fueling the expansion of the respiratory disease testing market from 2024 to 2030.

Which MedTech key players in the Respiratory Disease Testing market are set to emerge as the trendsetter explore @ Respiratory Disease Testing
https://www.delveinsight.com/sample-request/respiratory-disease-testing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Scope of the Respiratory Disease Testing Market Report
• Coverage: Global
• Study Period: 2021-2030
• Respiratory Disease Testing Market Segmentation By Product Type: Instruments and Reagents & Kits
• Respiratory Disease Testing Market By Test Type: Imaging, In-vitro Diagnostics, Mechanical Test, and Blood Gas Test)
• Respiratory Disease Testing Market Segmentation By End-User: Hospitals & Clinics, Diagnostics Centre, and Others
• Respiratory Disease Testing Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Respiratory Disease Testing Companies: Koninklijke Philips N.V., Niterra Co., Ltd., Thermo Fisher Scientific Inc., QIAGEN, Abbott, Danaher Corporation, Siemens Healthineers, Diasorin S.p.A, BD, GE Healthcare, QuantuMDx Group Ltd., BIOMÉRIEUX, SDI Diagnostics, COSMED srl, Seegene Inc., CAREstream Medical Ltd., Bird Healthcare, visby medical, Vitalograph, Bio-Rad Laboratories, Inc., and others.
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

Table of Contents
1 Respiratory Disease Testing Market Report Introduction
2 Respiratory Disease Testing Market Executive summary
3 Regulatory and Patent Analysis
4 Respiratory Disease Testing Market Key Factors Analysis
5 Porter's Five Forces Analysis
6 COVID-19 Impact Analysis on Respiratory Disease Testing Market
7 Respiratory Disease Testing Market Layout
8 Global Company Share Analysis - Key 3-5 Companies
9 Company and Product Profiles
10 Project Approach
11. About DelveInsight

Trending Reports:
• Advanced Recurrent Ovarian Cancer Market: https://www.delveinsight.com/report-store/advanced-recurrent-ovarian-cancer-market
• Aids Related Kaposi's Sarcoma Market: https://www.delveinsight.com/report-store/aids-related-kaposis-sarcoma-market
• Alkaptonuria Market: https://www.delveinsight.com/report-store/alkaptonuria-market
• Anti-gbm Market: https://www.delveinsight.com/report-store/anti-glomerular-basement-membrane-anti-gbm-disease-market-insights
• Cancer Anorexia Market: https://www.delveinsight.com/blog/cancer-anorexia-market
• Chronic Rhinosinusitis Phenotype With Nasal Polyps Market: https://www.delveinsight.com/report-store/chronic-rhinosinusitis-phenotype-with-nasal-polyps-market-insight
• Duchenne Muscular Dystrophy Market: https://www.delveinsight.com/report-store/duchenne-muscular-dystrophy-market
• Hyperopia Market: https://www.delveinsight.com/report-store/hyperopia-market
• Nonmuscle Invasive Bladder Cancer Market: https://www.delveinsight.com/report-store/non-muscle-invasive-bladder-cancer-market
• Oral Mucositis Om Market: https://www.delveinsight.com/report-store/oral-mucositis-om-market
• Severe Hypertriglyceridemia Market: https://www.delveinsight.com/report-store/severe-hypertriglyceridemia-shtg-market
• Antibody Mediated Rejection Market: https://www.delveinsight.com/report-store/antibody-mediated-rejection-market
• Bk Virus Infection Market: https://www.delveinsight.com/report-store/bk-virus-bkv-infection-market
• Human Papillomavirus Positive Cancer Market: https://www.delveinsight.com/report-store/human-papillomavirus-16-positive-hpv16-cancers-market
• Intrahepatic Cholangiocarcinoma Market: https://www.delveinsight.com/report-store/cholangiocarcinoma-cca-market-insights-epidemiology-and-market-forecast
• Anovulation Market: https://www.delveinsight.com/report-store/anovulation-market
• Anti-cd274 Pd-l1 Antibody Pipeline: https://www.delveinsight.com/report-store/anti-cd274-pd-l1-antibody-pipeline-insight
• Antibody-mediated Rejection Market: https://www.delveinsight.com/report-store/antibody-mediated-rejection-market
• Bone And Joint Infection Market: https://www.delveinsight.com/report-store/prosthetic-joint-infection-market
• Bradycardia Treatment Devices Market: https://www.delveinsight.com/report-store/bradycardia-treatment-devices-market
• Cardiorenal Syndrome Market: https://www.delveinsight.com/report-store/cardiorenal-syndrome-market
• Facioscapulohumeral Muscular Dystrophy Market: https://www.delveinsight.com/report-store/facioscapulohumeral-muscular-dystrophy-market
• Menorrhalgia Market: https://www.delveinsight.com/report-store/menorrhalgia-market
• Postmenopausal Vaginal Atrophy Market: https://www.delveinsight.com/infographics/atrophic-vaginitis-market
• Uncomplicated Urinary Tract Infections Market: https://www.delveinsight.com/report-store/uncomplicated-urinary-tract-infection-uuti-market
• Balloon Catheters Market: https://www.delveinsight.com/report-store/balloon-catheters-market
• Cervical Intraepithelial Neoplasia Market: https://www.delveinsight.com/report-store/cervical-cancer-market
• Cutaneous Lupus Erythematosus Market: https://www.delveinsight.com/report-store/cutaneous-lupus-erythematosus-market
• Vascular Dementia Market: https://www.delveinsight.com/report-store/vascular-dementia-market
• West Syndrome Market: https://www.delveinsight.com/report-store/west-syndrome-market

Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/consulting/conference-coverage-services

About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Respiratory Disease Testing Market to Sour at a CAGR of 5.14% by 2030, Evaluates DelveInsight | Koninklijke Philips N.V., Niterra Co., Ltd., Thermo Fisher Scientific Inc., QIAGEN, Abbott, Danaher Corporation, Siemens Healthineers here

News-ID: 3627353 • Views:

More Releases from DelveInsight Business Research

HER2-Negative Breast Cancer Pipeline and Clinical Trial Analysis: 70+ Players, 75+ Assets, and Key Clinical Breakthroughs, analyses DelveInsight
HER2-Negative Breast Cancer Pipeline and Clinical Trial Analysis: 70+ Players, 7 …
DelveInsight's "HER2-Negative Breast Cancer Pipeline Insight" report delivers an extensive analysis of more than 70 companies and 75 pipeline candidates shaping the HER2-negative breast cancer research landscape. The report features detailed profiles of investigational therapies across both clinical and preclinical stages of development. It also evaluates HER2-negative breast cancer treatments based on therapy type, development phase, route of administration, and molecular classification. In addition, the report identifies and reviews inactive
Marginal Zone Lymphoma Pipeline and Clinical Trial Analysis: 50+ Players, 50+ Assets, and Key Clinical Breakthroughs, analyses DelveInsight
Marginal Zone Lymphoma Pipeline and Clinical Trial Analysis: 50+ Players, 50+ As …
DelveInsight's "Marginal Zone Lymphoma Pipeline Insight" report delivers an in-depth analysis of more than 50 companies and 50+ investigational drugs shaping the Marginal Zone Lymphoma (MZL) pipeline ecosystem. The report comprehensively outlines Marginal Zone Lymphoma drug profiles, spanning both clinical-stage and non-clinical development programs. It further evaluates the Marginal Zone Lymphoma therapeutic landscape based on product classification, development phase, route of administration, and molecular category. Additionally, the report identifies and examines
Non-Muscle Invasive Bladder Cancer Pipeline and Clinical Trial Analysis: 20+ Players, 22+ Assets, and Key Clinical Breakthroughs, analyses DelveInsight
Non-Muscle Invasive Bladder Cancer Pipeline and Clinical Trial Analysis: 20+ Pla …
DelveInsight's "Non-Muscle Invasive Bladder Cancer Pipeline Insight" report delivers an in-depth analysis of more than 20 companies and over 22 investigational therapies shaping the NMIBC pipeline landscape. The report features comprehensive profiles of pipeline candidates, spanning both clinical and preclinical stages of development. It also presents a detailed therapeutic evaluation of NMIBC drugs based on product category, development phase, route of administration, and molecular classification. In addition, the study sheds light on discontinued
Myocardial Infarction Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes
Myocardial Infarction Market to Evolve Rapidly Over the Next Decade by 2034, Del …
DelveInsight's "Myocardial Infarction Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Myocardial Infarction, historical and forecasted epidemiology as well as the Myocardial Infarction market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Myocardial Infarction market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Myocardial Infarction Market Forecast https://www.delveinsight.com/sample-request/myocardial-infarction-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Some of the

All 5 Releases


More Releases for Test

Key Differences Between Megger Test, Tan Delta Test, and Hi-Pot Test for Electri …
Electrical insulation plays a critical role in ensuring the safety and efficiency of electrical systems. To assess the condition of insulation and identify potential issues, three common tests are used: the Megger test, Tan Delta test, and Hi-Pot test. Each test serves a unique purpose and provides valuable insights into the state of electrical insulation. Here's a closer look at the differences between these three essential tests. Megger Test: Insulation Resistance
Vitamin Test Market: Global Vitamin Test Analysis and Forecast (2023-2029)Vitami …
12.04.2024: Vitamin Test Market Overview The development of companion diagnostic tools and advances in personalised treatment are driving considerable growth and revolution in the oncology Vitamin Test market. In the era of precision medicine, where healthcare is increasingly customised for individual individuals based on their own genetic and molecular profiles, this market segment is essential. Ongoing innovation and development define the oncology Vitamin Test market. To find particular biomarkers, genetic mutations,
CAGR 8.1% Homecare Pregnancy Test Kits Market By Type of Test (Urine Test For H …
The Homecare Pregnancy Test Kits market report by Reports and Data provides an extensive overview of the vital elements of the Homecare Pregnancy Test Kits market and factors such as the drivers, restraints, latest trends, supervisory scenario, competitive landscape, technological advancements, and others. Further, it mentions the market shares associated with the market in terms of both value and volume along with the segmentation. Space-age industrial and digitalization tools are
Home Safety Test Kits Market, Home Safety Test Kits Market Trends, Home Safety T …
“Home Safety Test Kits Market” 2020-2025 Research Report is a professional and in-depth study on the current state of the market. Global Home Safety Test Kits market containing a complete view of the market size, business share, profit estimates, SWOT analysis and the regional landscape of the Industry. The report explains key challenges and future development prospects of the market. The Global Home Safety Test Kits analysis is provided for
Test Data Management (TDM) Market - test data profiling, test data planning, tes …
The report categorizes the global Test Data Management (TDM) market by top players/brands, region, type, end user, market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors. This report studies the global market size of Test Data Management (TDM) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption
Hearing Screening and Diagnostic Devices Market Demands with Major Tests: pure T …
New Market Research Reports Title "Hearing Screening And Diagnostic Devices Market 2018" Has Been Added to Crystal Market Research Report database. Hearing Screening and Diagnostic Devices - Competitive Insights: The leading players in the market are Gn Otometrics A/S, Otodynamics, Nashua Hearing Group, Siemens Healthineers, Natus Medical Incorporated, Interacoustics A/S, Neurosoft S.A, Accent Hearing Pty Ltd, MAICO Diagnostics GmbH and IntriCon Corporation. The major players in the market are profiled in detail